Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

Market Cap	17.24B
Revenue (ttm)	1.47B
Net Income (ttm)	43.93M
Shares Out	966.49M
EPS (ttm)	0.05
PE Ratio	392.46
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,323,201
Average Volume	20,263,519
Open	18.21
Previous Close	17.84
Day's Range	17.87 - 18.30
52-Week Range	12.66 - 19.85
Beta	0.27
RSI	62.92
Earnings Date	Apr 18, 2025

About SHE:000766

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides bone peptides, protective chemical medicines, cardiovascular and cerebrovascular chinese patent medicines, heat-clearing and detoxifying medicines, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 1,696
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000766

Financial Performance

In 2023, SHE:000766's revenue was 1.47 billion, an increase of 0.18% compared to the previous year's 1.47 billion. Earnings were 43.93 million, an increase of 45.71%.